(Q36735756)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300581%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Chlamydia pneumoniae and age-related macular degeneration: a role in pathogenesis or merely a chance association? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300581%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Chlamydia pneumoniae

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300581%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Luba Robman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300581%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300581%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Ophthalmology

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300581%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300581%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300581%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

89-93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300581%20AND%20SRC:MED&resulttype=core&format=json

Five-year incidence of bilateral cause-specific visual impairment in the Melbourne Visual Impairment Project

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Causes of visual impairment in two older population cross-sections: the Blue Mountains Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Causes and prevalence of visual impairment among adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

The prevalence of age-related maculopathy by geographic region and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

The prevalence of age-related maculopathy: the visual impairment project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Smoking and age-related macular degeneration: a review of association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Immunological and aetiological aspects of macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

A potential role for immune complex pathogenesis in drusen formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Complement activation and inflammatory processes in Drusen formation and age related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Association between C-reactive protein and age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Complement factor H variant increases the risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Complement factor H polymorphism and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Complement factor H polymorphism in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Biology of complement: the overture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

The alternative pathway of complement in disease: opportunities for therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Evidence for infectious agents in cardiovascular disease and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Chlamydia pneumoniae in infrequently examined blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Chlamydia pneumoniae in atherosclerotic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Azithromycin for the secondary prevention of coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Serological Association Between Chlamydia pneumoniae Infection and Age-Related Macular Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Methodology of the Cardiovascular Health and Age-Related Maculopathy (CHARM) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Infections caused by Chlamydia pneumoniae strain TWAR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Prevalence of antibodies to Chlamydia pneumoniae TWAR in a group of German medical students

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

The chlamydial developmental cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

The role of Chlamydia pneumoniae in multiple sclerosis: real or fictitious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

Advances in the management of Chlamydia pneumoniae infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

A role for the C3a anaphylatoxin receptor in the effector phase of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-9071.2006.01392.X

10.1111/J.1442-9071.2006.01392.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17300581%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference